| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13G/A | 2024-02-14 | Mosca Alison | Clene Inc. | 12,857,926 | 9.6% | EDGAR |
| SC 13G/A | 2024-02-14 | CITADEL ADVISORS LLC | Clene Inc. | - | 4.3% | EDGAR |
| SC 13G | 2024-02-14 | AWM Investment Company, Inc. | Clene Inc. | 12,691,213 | 9.2% | EDGAR |
| SC 13G/A | 2024-02-13 | Vivo Opportunity Fund Holdings, L.P. | Clene Inc. | 12,500,000 | 7.0% | EDGAR |
| SC 13G | 2023-09-11 | Ugwumba Chidozie | Clene Inc. | 28,018,908 | 19.9% | EDGAR |
| SC 13G | 2023-07-03 | CITADEL ADVISORS LLC | Clene Inc. | - | 5.7% | EDGAR |
| SC 13G | 2023-06-28 | Vivo Opportunity Fund Holdings, L.P. | Clene Inc. | 17,737,800 | 10.0% | EDGAR |
| SC 13D/A | 2023-06-20 | MATLIN DAVID J | Clene Inc. | 7,146,990 | 5.6% | EDGAR |
| SC 13D/A | 2023-02-21 | MATLIN DAVID J | Clene Inc. | 5,604,362 | 7.6% | EDGAR |
| SC 13D/A | 2023-02-17 | FOLEY & LARDNER/ FA | Clene Inc. | 5,601,862 | 7.6% | EDGAR |
| SC 13D/A | 2023-02-13 | Ugwumba Chidozie | Clene Inc. | 5,518,908 | 7.5% | EDGAR |
| SC 13D | 2023-02-06 | FOLEY & LARDNER/ FA | Clene Inc. | 5,601,862 | 7.6% | EDGAR |
| SC 13G/A | 2023-02-02 | UNITED THERAPEUTICS Corp | Clene Inc. | 2,869,517 | 3.9% | EDGAR |
| SC 13G/A | 2023-01-17 | UNITED THERAPEUTICS Corp | Clene Inc. | 2,869,517 | 3.9% | EDGAR |
| SC 13D | 2022-02-14 | Ugwumba Chidozie | Clene Inc. | 4,616,854 | 7.4% | EDGAR |
| SC 13G | 2022-02-14 | Walton Thomas Layton | Clene Inc. | 0 | 0.0% | EDGAR |
| SC 13G | 2022-02-14 | Mosca Alison | Clene Inc. | 5,509,160 | 8.7% | EDGAR |
| SC 13G/A | 2022-01-14 | UNITED THERAPEUTICS Corp | Clene Inc. | 3,656,092 | 5.9% | EDGAR |
| SC 13G | 2021-08-06 | General Resonance LLC | Clene Inc. | 15,976,273 | 26.8% | EDGAR |
| SC 13G/A | 2021-02-16 | PERISCOPE CAPITAL INC. | Clene Inc. | - | - | EDGAR |